相关实验视频
Updated: Jul 19, 2026

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.0K
创新性动脉样硬化模型:促进病理生理学和转化研究的进步
Huiting Jiang1,2, Yukun Liao3, Mengliang Zhu4,5
1Department of Cardiology, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Research (Washington, D.C.)
|March 6, 2025
概括
本综述探讨了高级动脉样硬化 (AS) 模型,包括组织工程血管和芯片上的血管,以更好地了解这种复杂的炎症性疾病. 这些模型提供了更好的洞察力AS进展和潜在的治疗应用.
科学领域:
- 生物医学工程 生物医学工程
- 心血管研究研究心血管研究
- 病理学 病理学 病理学
背景情况:
- 动脉样硬化 (AS) 是一种复杂的慢性炎症性疾病,由代谢,氧化和血栓性因素驱动.
- 准确的实验模型对于阐明AS病原和进展至关重要.
- 目前的模型需要对其在模拟人类AS中的实用性进行评估.
研究的目的:
- 审查和分析目前用于动脉样硬化研究的实验模型.
- 讨论各种AS模型的特定应用场景.
- 突出先进模型的潜力,用于神经预测应用.
主要方法:
- 审查关于动脉样硬化模型的现有文献.
- 组织工程血管 (TEBVs) 和芯片上的血管 (VoCs) 的分析用于体外建模.
- 讨论动物模型,包括那些由高脂肪饮食和基因编辑引起的动物模型.
- 作为研究工具,对孤立的动物容器段进行检查.
主要成果:
- TEBV和VoC提供体外模型,其结构和功能与人类AS非常相似.
- 孤立的动物血管部分为AS研究提供了生理上相似,可控制和可复制的平台.
- 通过饮食和基因编辑增强的动物模型通过结合免疫-炎症,机械和血液动力学因素有效模拟AS.
结论:
- 先进的体外和体内模型显著提高了对动脉样硬化的研究.
- 这些模型有望在临床翻译研究中彻底改变术术应用.
- 改进的AS模型为个性化和有效的未来治疗铺平了道路.
相关概念视频
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

